Stereotaxis is trading at $1.04, up 9.17%, with no clear catalyst identified.
- No November 5 company-specific announcement was identified; the latest listed release was November 2.
- The reported broad-market sell-off moved in the opposite direction. Reuters described sharp index losses amid technology and AI-infrastructure concerns.
- Stereotaxis is scheduled to report third-quarter 2026 results on November 10.